Skip to main content
SpringerLink
Log in
Book cover

Pediatric Acute Respiratory Distress Syndrome pp 117–126Cite as

Ancillary Pulmonary Treatments for Pediatric Acute Respiratory Distress Syndrome

  • Chapter
  • First Online:

Abstract

Treatments for pediatric acute respiratory distress syndrome (PARDS) targeting the pulmonary system, other than mechanical ventilation, will be reviewed in this chapter. Many approaches have been used, but unfortunately, there is little medical evidence to guide clinicians in the appropriate use of them. The prone position, inhaled nitric oxide, and surfactant have been studied but have failed to consistently show improved outcomes in children with PARDS. Corticosteroids and the appropriate application of respiratory care, such as pulmonary hygiene, are less well studied. Clinicians are forced to apply limited pediatric research and studies on adult patients to guide the care of children with PARDS. Several therapies may be considered on a case-by-case basis after weighing potential benefits against the risks and costs of the therapy, but no ancillary pulmonary treatment would be considered standard of care in PARDS.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Johnson NJ, Luks AM, Glenny RW. Gas exchange in the prone posture. Respir Care. 2017;62:1097–110.

    Article  Google Scholar 

  2. Piehl MA, Brown RS. Use of extreme position changes in acute respiratory failure. Crit Care Med. 1976;4:13–4.

    Article  CAS  Google Scholar 

  3. Curley MA, Thompson JE, Arnold JH. The effects of early and repeated prone positioning in pediatric patients with acute lung injury. Chest. 2000;118:156–63.

    Article  CAS  Google Scholar 

  4. Kornecki A, Frndova H, Coates AL, et al. 4A randomized trial of prolonged prone positioning in children with acute respiratory failure. Chest. 2001;119:211–8.

    Article  CAS  Google Scholar 

  5. Bruno F, Piva JP, Garcia PC, et al. Short-term effects of prone positioning on the oxygenation of pediatric patients submitted to mechanical ventilation. J Pediatr. 2001;77:361–8.

    CAS  Google Scholar 

  6. Casado-Flores J, Martinez de Azagra A, Ruiz-Lopez MJ, et al. Pediatric ARDS: effect of supine-prone postural changes on oxygenation. Intensive Care Med. 2002;28:1792–6.

    Article  Google Scholar 

  7. Curley MA, Hibberd PL, Fineman LD, et al. Effect of prone positioning on clinical outcomes in children with acute lung injury: a randomized controlled trial. JAMA. 2005;294:229–37.

    Article  CAS  Google Scholar 

  8. Fineman LD, LaBrecqu MA, Shih MC, et al. Prone positioning can be safely performed in critically ill infants and children. Pediatr Crit Care Med. 2006;7:413–22.

    Article  Google Scholar 

  9. Sud S, Sud M, Friedrich JO, et al. Effect of prone positioning in patients with acute respiratory distress syndrome and high simplified acute physiology score II. Crit Care Med. 2008;36:2711–2.

    Article  Google Scholar 

  10. Sud S, Friedrich JO, Taccone P, et al. Prone ventilation reduces mortality in patients with acute respiratory failure and severe hypoxemia: systematic review and meta-analysis. Intensive Care Med. 2010;36:585–99.

    Article  Google Scholar 

  11. Guérin C, Reignier J, Ricjhard JC, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368:2159–68.

    Article  Google Scholar 

  12. Relvas MS, Silver PC, Sagy M. Prone positioning of pediatric patients with ARDS results in improvement in oxygenation if maintained > 12 h daily. Chest. 2003;124:269–74.

    Article  Google Scholar 

  13. Sheridan RL, Zapol WM, Ritz RH, et al. Low-dose inhaled nitric oxide in acutely burned children with profound respiratory failure. Surgery. 1999;126:856–62.

    Article  CAS  Google Scholar 

  14. Tang SF, Sherwood MC, Miller OI. Randomised trial of three doses of inhaled nitric oxide in acute respiratory distress syndrome. Arch Dis Child. 1998;79:415–8.

    Article  CAS  Google Scholar 

  15. Day RW, Allen EM, Witte MK. A randomized, controlled study of the 1-hour and 24-hour effects of inhaled nitric oxide therapy in children with acute hypoxemic respiratory failure. Chest. 1997;112:1324–31.

    Article  CAS  Google Scholar 

  16. Dobyns EL, Cornfield DN, Anas NG, et al. Multicenter randomized controlled trial of the effects of inhaled nitric oxide therapy on gas exchange in children with acute hypoxemic respiratory failure. J Pediatr. 1999;134:406–12.

    Article  CAS  Google Scholar 

  17. Afshari A, Brok J, Møller AM, et al. Inhaled nitric oxide for acute respiratory distress syndrome and acute lung injury in adults and children: a systematic review with meta-analysis and trial sequential analysis. Anesth Analg. 2011;112:1411–21.

    Article  Google Scholar 

  18. Macrae DJ, Field D, Mercier JC, et al. Inhaled nitric oxide therapy in neonates and children: reaching a European consensus. Intensive Care Med. 2004;30:372–80.

    Article  Google Scholar 

  19. Tamburro RF, Kneyber MCJ. Pulmonary specific ancillary treatment for pediatric acute respiratory distress syndrome: proceedings from the pediatric acute lung injury consensus conference. Pediatr Crit Care Med. 2015;16:S61–72.

    Article  Google Scholar 

  20. Thomas CA, Valentine K. Utility of routine methemoglobin laboratory assays in critically ill pediatric subjects receiving inhaled nitric oxide. J Crit Care. 2018;48:63–5.

    Article  CAS  Google Scholar 

  21. Howard LS, Morrell NW. New therapeutic agents for pulmonary vascular disease. Paediatr Respir Rev. 2005;6:285–91.

    Article  Google Scholar 

  22. Cornet AD, Hofstra JJ, Swart EL, et al. Sildenafil attenuates pulmonary arterial pressure but does not improve oxygenation during ARDS. Intensive Care Med. 2010;36:758–64.

    Article  CAS  Google Scholar 

  23. Peter JV, John P, Graham PL, et al. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ. 2008;336:1006–9.

    Article  Google Scholar 

  24. Tang BM, Craig JC, Eslick GD, et al. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med. 2009;37:1594–603.

    Article  CAS  Google Scholar 

  25. Tizon R, Frey N, Heitjan DF, et al. High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after Allo-SCT. Bone Marrow Transplant. 2012;47:1332–7.

    Article  CAS  Google Scholar 

  26. Yanik G, Grupp S, Pulsipher MA, et al. Competitive TNF inhibitor (ETANERCEPT) for the treatment of idiopathic pneumonia syndrome (IPS) following allogeneic stem cell transplantation (SCT). A joint pediatric blood and marrow transplant consortium (PBMTC) and children’s oncology group (COG) study. Biol Blood Marrow Transplant. 2013;19:S111–2.

    Article  Google Scholar 

  27. Yanik G, Ho VT, Horowitz M, et al. Randomized, double blind, placebo-controlled trial of a TNF inhibitor (ETANERCEPT) for the treatment of idiopathic pneumonia syndrome (IPS) after allogeneic stem cell transplant (SCT). A blood and marrow transplant clinical trials network (BMT CTN) study. Biol Blood Marrow Transplant. 2013;19:S169.

    Article  Google Scholar 

  28. Petty TL, Reiss OK, Paul GW, et al. Characteristics of pulmonary surfactant in adult respiratory distress syndrome associated with trauma and shock. Am Rev Respir Dis. 1977;115:531–6.

    CAS  PubMed  Google Scholar 

  29. Hallman M, Spragg R, Harrell JH, et al. Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J Clin Invest. 1982;70:673–83.

    Article  CAS  Google Scholar 

  30. Gregory TJ, Longmore WJ, Moxley MA, et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest. 1991;88:1976–81.

    Article  CAS  Google Scholar 

  31. Willson DF, et al. Calf’s lung surfactant extract in acute hypoxemic respiratory failure in children. Crit Care Med. 1996;24(8):1316–22.

    Article  CAS  Google Scholar 

  32. Luchetti M, Casiraghi G, Valsecchi R, et al. Porcine-derived surfactant treatment of severe bronchiolitis. Acta Anaesthesiol Scand. 1998;42:805–10.

    Article  CAS  Google Scholar 

  33. Luchetti M, Ferrero F, Gallini C, et al. Multicenter, randomized, controlled study of porcine surfactant in severe respiratory syncytial virus-induced respiratory failure. Pediatr Crit Care Med. 2002;3:261–8.

    Article  Google Scholar 

  34. Willson DF, Zaritsky A, Bauman LA, et al. Instillation of calf lung surfactant extract (calfactant) is beneficial in pediatric acute hypoxemic respiratory failure. Members of the Mid-Atlantic Pediatric Critical Care Network. Crit Care Med. 1999;27:188–95.

    Article  CAS  Google Scholar 

  35. Möller JC, Schaible T, Roll C, et al. Surfactant ARDS study group. Treatment with bovine surfactant in severe acute respiratory distress syndrome in children: a randomized multicenter study. Intensive Care Med. 2003;29:437–46.

    Article  Google Scholar 

  36. Willson DF, Thomas NJ, Markovitz BP, et al. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. JAMA. 2005;293:470–6.

    Article  CAS  Google Scholar 

  37. Thomas NJ, Spear D, Wasserman E, et al. CALIPSO: a randomized controlled trial of calfactant for acute lung injury in pediatric stem cell and oncology patients. Biol Blood Marrow Transplant. 2018;24:2479–86.

    Article  CAS  Google Scholar 

  38. Willson DF, Thomas NJ, Tamburro R, et al. Pediatric calfactant in acute respiratory distress syndrome trial. Pediatr Crit Care Med. 2013;14:657–65.

    Article  Google Scholar 

  39. Choong K, Chatrkaw P, Frndova H, et al. Comparison of loss in lung volume with open versus in-line catheter endotracheal suctioning. Pediatr Crit Care Med. 2003;4:69–73.

    Article  Google Scholar 

  40. Boothroyd AE, Murthy BV, Darbyshire A, et al. Endotracheal suctioning causes right upper lobe collapse in intubated children. Acta Paediatr. 1996;85:1422–5.

    Article  CAS  Google Scholar 

  41. Ridling DA, Martin LD, Bratton SL. Endotracheal suctioning with or without instillation of isotonic sodium chloride solution in critically ill children. Am J Crit Care. 2003;12:212–9.

    PubMed  Google Scholar 

  42. Shein SL, Gallagher JT, Deakins KM. Prophylactic use of nebulized hypertonic saline in mechanically ventilated children: a randomized blinded pilot study. Respir Care. 2016;61:586–92.

    Article  Google Scholar 

  43. Singh B, Tiwari AK, Singh K, et al. β2 agonist for the treatment of acute lung injury: A systematic review and meta-analysis. Respir Care. 2014;59:288–96.

    Article  Google Scholar 

  44. Abu-Hasan MN, Chesrown SE, Jantz MA. Successful use of bronchoscopic lung insufflation to treat left lung atelectasis. Pediatr Pulmonol. 2013;48:306–9.

    Article  Google Scholar 

  45. Nakamura CT, Ripka JF, McVeigh K, et al. Bronchoscopic instillation of surfactant in acute respiratory distress syndrome. Pediatr Pulmonol. 2001;31:317–20.

    Article  CAS  Google Scholar 

  46. Rafat N, Tönshoff B, Bierhaus A, Beck GC. Endothelial progenitor cells in regeneration after acute lung injury: do they play a role? Am J Respir Cell Mol Biol. 2013;48:399–405.

    Article  CAS  Google Scholar 

  47. Lam CF, Liu YC, Hsu JK, et al. Autologous transplantation of endothelial progenitor cells attenuates acute lung injury in rabbits. Anesthesiology. 2008;108:392–401.

    Article  Google Scholar 

  48. Mao M, Wang SN, Lv XJ, et al. Intravenous delivery of bone marrow-derived endothelial progenitor cells improves survival and attenuates lipopolysaccharide-induced lung injury in rats. Shock. 2010;34:196–204.

    Article  Google Scholar 

  49. Zhu H, Xiong Y, Xia Y, et al. Therapeutic effects of human umbilical cord-derived mesenchymal stem cells in acute lung injury mice. Sci Rep. 2017;7:39889.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA

    Andrew L. Beardsley

Authors
  1. Andrew L. Beardsley
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew L. Beardsley .

Editor information

Editors and Affiliations

  1. Rainbow Babies & Children’s Hospital, Case Western Reserve University, Cleveland, OH, USA

    Steven L. Shein

  2. Duke University School of Medicine, Duke University Medical Center, Durham, NC, USA

    Alexandre T. Rotta

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Beardsley, A.L. (2020). Ancillary Pulmonary Treatments for Pediatric Acute Respiratory Distress Syndrome. In: Shein, S., Rotta, A. (eds) Pediatric Acute Respiratory Distress Syndrome. Springer, Cham. https://doi.org/10.1007/978-3-030-21840-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-21840-9_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-21839-3

  • Online ISBN: 978-3-030-21840-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation